Anti-NFkB p65 Rabbit Monoclonal Antibody [RM273] 31-1154-00 from RevMAb Biosciences USA, Inc. | Biocompare.com

Be the first to write a review!

Supplier Page from
RevMAb Biosciences USA, Inc. for
Anti-NFkB p65 Rabbit Monoclonal Antibody [RM273]

RevMAb Biosciences USA, Inc.'s Anti-NFkB p65 Rabbit Monoclonal Antibody [RM273] is a Rabbit monoclonal antibody. The Anti-NFkB p65 Rabbit Monoclonal Antibody [RM273] was generated using RELA as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Immunohistochemistry, and Western Blot.

Product Specs
ItemAnti-NFkB p65 Rabbit Monoclonal Antibody [RM273]
CompanyRevMAb Biosciences USA, Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog Number31-1154-00
Quantity100 uL
ApplicationsWB, IHC
Conjugate/TagUnconjugated
Format50% Glycerol/PBS with 1% BSA and 0.09% sodium azide
PurityProtein A affinity purified from an animal origin-free culture supernatant
ReactivityHuman
TargetNFkB p65
IsotypeIgG
CloneRM273
HostRabbit
ImmunogenA peptide corresponding to the area near the C-terminus of human transcription factor p65 (NFkB p65 subunit)
NCBI Full Gene NameRELA proto-oncogene, NF-kB subunit
NCBI Gene AliasesNFKB3, p65
ClonalityMonoclonal
Antibody TypeRecombinant

Add to Compare List

RevMAb Biosciences USA, Inc.

RevMAb Biosciences USA, Inc.

830 Dubuque Avenue

South San Francisco, California 94080

United States

Phone: Tel: 650-351-7325
Fax: 650-351-7323

Email: info@revmab.com
order@revmab.com
support@revmab.com

Company Profile

Website: RevMAb Biosciences

Be the First to Write a Review!

The Magic’s In the Membrane: Choose Wisely for Best Western Blot Results
April 08, 2013
It is important to validate the correct membrane type for your experimental conditions. Choosing the correct membrane type for Western blotting can help prevent transfer inefficiencies, reduce background after staining ... read more

Watch Video: The Immobilon^® Family - a Western story
Western blotting is one of the most commonly used techniques in the lab, yet difficulties persist in... Read More